BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2593915)

  • 1. Prolonged hepatic cholestasis after flucloxacillin therapy.
    Turner IB; Eckstein RP; Riley JW; Lunzer MR
    Med J Aust; 1989 Dec 4-18; 151(11-12):701-5. PubMed ID: 2593915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flucloxacillin-induced cholestatic liver damage.
    Bengtsson F; Florén CH; Hägerstrand I; Söderström C; Aberg T
    Scand J Infect Dis; 1985; 17(1):125-8. PubMed ID: 3992199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flucloxacillin induced delayed cholestatic hepatitis.
    Miros M; Kerlin P; Walker N; Harris O
    Aust N Z J Med; 1990 Jun; 20(3):251-3. PubMed ID: 2372276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis.
    Davies MH; Harrison RF; Elias E; Hübscher SG
    J Hepatol; 1994 Jan; 20(1):112-6. PubMed ID: 8201211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of floxacillin on the liver. 3 cases of floxacillin-induced cholestatic liver disease].
    Götell P; Lööf L
    Lakartidningen; 1987 Mar; 84(12):954-5. PubMed ID: 3573872
    [No Abstract]   [Full Text] [Related]  

  • 6. Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization.
    Victorino RM; Maria VA; Correia AP; de Moura C
    Arch Intern Med; 1987 May; 147(5):987-9. PubMed ID: 3579450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flucloxacillin induced liver disease: histopathological findings at biopsy and autopsy.
    Eckstein RP; Dowsett JF; Lunzer MR
    Pathology; 1993 Jul; 25(3):223-8. PubMed ID: 8265236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of icterus after floxacillin treatment].
    Thune A; Zackrisson B
    Lakartidningen; 1987 Mar; 84(12):955. PubMed ID: 3573873
    [No Abstract]   [Full Text] [Related]  

  • 9. Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?
    Devereaux BM; Crawford DH; Purcell P; Powell LW; Roeser HP
    Eur J Clin Pharmacol; 1995; 49(1-2):81-5. PubMed ID: 8751026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is flucloxacillin-induced liver damage an underreported complication?].
    Friis-Liby I; Meresaar U; Olsson KS
    Lakartidningen; 1999 Oct; 96(42):4535-6. PubMed ID: 10575859
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver damage from flucloxacillin, cloxacillin and dicloxacillin.
    Olsson R; Wiholm BE; Sand C; Zettergren L; Hultcrantz R; Myrhed M
    J Hepatol; 1992 May; 15(1-2):154-61. PubMed ID: 1506634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for development of flucloxacillin associated jaundice.
    Fairley CK; McNeil JJ; Desmond P; Smallwood R; Young H; Forbes A; Purcell P; Boyd I
    BMJ; 1993 Jan; 306(6872):233-5. PubMed ID: 8443520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk of liver reactions after treatment with flucloxacillin].
    Lakartidningen; 1989 Mar; 86(11):977-8. PubMed ID: 2927200
    [No Abstract]   [Full Text] [Related]  

  • 14. Flucloxacillin-associated liver damage.
    Lobatto S; Dijkmans BA; Mattie H; Van Hooff JP
    Neth J Med; 1982; 25(2):47-8. PubMed ID: 7070561
    [No Abstract]   [Full Text] [Related]  

  • 15. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
    Hubscher SG; Lumley MA; Elias E
    Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flucloxacillin-induced haemolytic anaemia.
    Tuffs L; Manoharan A
    Med J Aust; 1986 May; 144(10):559-60. PubMed ID: 3713580
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversible cholestasis with bile duct injury following azathioprine therapy. A case report.
    Horsmans Y; Rahier J; Geubel AP
    Liver; 1991 Apr; 11(2):89-93. PubMed ID: 2051906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flucloxacillin nephritis.
    Westberg NG; Björck S
    Clin Nephrol; 1983 May; 19(5):269. PubMed ID: 6851267
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful liver transplantation for drug-induced vanishing bile duct syndrome.
    Hashim A; Barnabas A; Miquel R; Agarwal K
    BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31948982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flucloxacillin-Induced Hepatotoxicity - Association with HLA-B*5701.
    Teixeira M; Macedo S; Batista T; Martins S; Correia A; Matos LC
    Rev Assoc Med Bras (1992); 2020; 66(1):12-17. PubMed ID: 32130375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.